Blend Labs, Inc. BLND
1.11
0.04
3.74%
as of 25 Sep
- Market cap
- $253.1M
- P/E
- 0.0×
Follow BLND
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
3.16 | 3.41 | 6.37 | 7.80 | |
P/FCF ratio |
54.31 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
51.75 | 59.11 | 803.27 | (307.48) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.88 | 4.03 | 6.93 | 8.31 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
38.27 | (410.85) | 74.38 | 169.74 | |
EV/FCF |
66.75 | (53.31) | (10,571.10) | (141.27) | |
Quick Ratio |
1.27 | 1.50 | 1.99 | 1.96 | |
Current Ratio |
1.62 | 1.81 | 2.53 | 2.54 | |
Net Debt/EBITDA |
(131.19) | 18.89 | 31.93 | 23.48 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.79 | 0.73 | 0.71 | 0.65 | |
Operating CF/Net income |
(1.24) | (0.58) | (0.13) | (0.39) | |
Capex/Depreciation |
(0.43) | (0.58) | (0.55) | (1.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
25.66% | 30.52% | 27.88% | 25.93% | |
Selling, General and Administrative Expense of Revenue |
52.53% | 59.50% | 60.00% | 63.15% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
20.62% | 21.98% | 23.50% | 23.43% | |
Graham Net Nets |
(0.35) | (0.29) | (0.13) | (0.09) | |
Graham Number |
0.75 | 0.67 | 0.49 | 0.31 | |
Earnings Yield |
(4.68%) | (5.29%) | (2.96%) | (2.47%) | |
Free Cash Flow Yield |
1.84% | (2.22%) | (0.01%) | (0.75%) | |
Revenue per Share |
0.14 | 0.12 | 0.12 | 0.13 | |
Operating CF per Share |
0.03 | 0.03 | 0.00 | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
0.03 | 0.02 | 0.00 | (0.02) | |
Cash per Share |
0.19 | 0.23 | 0.27 | 0.30 | |
Shareholders Equity per Share |
(0.31) | (0.22) | (0.12) | (0.05) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.31) | (0.22) | (0.12) | (0.05) | |
Free Cash Flow |
7.10 | 6.24 | (0.02) | (5.76) | |
Working Capital |
29.18 | 41.65 | 60.35 | 70.32 | |
Capital Expenditures |
(0.82) | (1.12) | (1.00) | (2.68) | |
Net Current Asset Value |
(142.05) | (124.07) | (100.72) | (86.06) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.04 | 0.03 | 0.08 | |
Net Profit Margin |
(18.94%) | (41.44%) | (23.77%) | 24.27% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
14.69 | 14.29 | 11.72 | 14.05 | |
Average Payables |
0.81 | 1.46 | 1.74 | 1.32 | |
Average Assets |
163.32 | 174.76 | 174.07 | 187.85 | |
Average Common Equity |
(48.47) | (36.40) | (43.41) | (31.04) |
Columns are period end dates